Clinical management of patients with pulmonary and extrapulmonary tuberculosis, multidrug-resistant and extensively resistant forms, use of new drugs (bedaquiline, pretomanid, delamanid, etc), personalization of antituberculosis therapy, global and local epidemiology of tuberculosis.
Screening and treatment of TB infection and infection control.
Collaboration with national and international research groups (Global TB Network).
Clinical management of patients with non-tuberculous mycobacteriosis, and other pulmonary infections (actinomycosis, nocardiosis, aspergillosis, etc).Collaboration with a national research group on NTM and participation in the national registry of pulmonary mycobacteriosis (IRENE registry).
Traveler and migrant diseases. Emerging infections.
Infectious disease screening in vulnerable populations.
